Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (441-450 of 461) with videos related to

Pageof 47
Sort By:
JACC. Heart Failure|February 7, 2021
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HFJoão Pedro Ferreira, Job Verdonschot, Ping Wang, et al.
Kidney International|January 4, 2026
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)Jodie L Babitt, Jeffrey S Berns, Biykem Bozkurt, et al.
European Journal of Heart Failure|July 3, 2025
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND studyAndreas P Kalogeropoulos, Ishaque Hameed, Stefan D Anker, et al.
Trials|September 10, 2021
Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapyNicole Evangelidis, Benedicte Sautenet, Magdalena Madero, et al.
European Heart Journal|November 20, 2020
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trialJohn G F Cleland, João Pedro Ferreira, Beatrice Mariottoni, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 18, 2024
Outcomes for clinical trials involving adults with chronic kidney disease: a multinational Delphi survey involving patients, caregivers and health professionalsAndrea Matus Gonzalez, Nicole Evangelidis, Martin Howell, et al.
European Journal of Heart Failure|April 21, 2021
Urinary peptides in heart failure: a link to molecular pathophysiologyTianlin He, Michaela Mischak, Andrew L Clark, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2016
The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST StudyClaudia Torino, Luna Gargani, Rosa Sicari, et al.
Journal of Nephrology|January 10, 2020
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal studyClaudia Torino, Luna Gargani, Rosa Sicari, et al.
American Journal of Nephrology|February 9, 2026
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) TrialSunil V Badve, Maha Al Ammari, Craig S Anderson, et al.
Pageof 47

Showing results (441-450 of 461) with videos related to

Sort By:
Pageof 47
JACC. Heart Failure|February 7, 2021
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HFJoão Pedro Ferreira, Job Verdonschot, Ping Wang, et al.
Kidney International|January 4, 2026
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)Jodie L Babitt, Jeffrey S Berns, Biykem Bozkurt, et al.
European Journal of Heart Failure|July 3, 2025
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND studyAndreas P Kalogeropoulos, Ishaque Hameed, Stefan D Anker, et al.
Trials|September 10, 2021
Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapyNicole Evangelidis, Benedicte Sautenet, Magdalena Madero, et al.
European Heart Journal|November 20, 2020
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trialJohn G F Cleland, João Pedro Ferreira, Beatrice Mariottoni, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 18, 2024
Outcomes for clinical trials involving adults with chronic kidney disease: a multinational Delphi survey involving patients, caregivers and health professionalsAndrea Matus Gonzalez, Nicole Evangelidis, Martin Howell, et al.
European Journal of Heart Failure|April 21, 2021
Urinary peptides in heart failure: a link to molecular pathophysiologyTianlin He, Michaela Mischak, Andrew L Clark, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2016
The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST StudyClaudia Torino, Luna Gargani, Rosa Sicari, et al.
Journal of Nephrology|January 10, 2020
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal studyClaudia Torino, Luna Gargani, Rosa Sicari, et al.
American Journal of Nephrology|February 9, 2026
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) TrialSunil V Badve, Maha Al Ammari, Craig S Anderson, et al.
Pageof 47